Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Clinical trial NCT05239169 · COMPLETED

Trial details

NCT number: NCT05239169
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer (CCA)Intrahepatic Cholangiocarcinoma Hilar Cholangiocarcinoma Distal Cholangiocarcinoma Gall Bladder Carcinoma

Start date: 2022-05-23
Primary completion: 2025-02-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.